WallStreetZenWallStreetZen

NASDAQ: ITRM
Iterum Therapeutics PLC Stock Ownership - Who owns Iterum Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iterum Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michael W. DunneDirector2025-08-0815,000$0.72
$10.86kBuy

1 of 1

ITRM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITRM insiders and whales buy or sell their stock.

ITRM Shareholders

What type of owners hold Iterum Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP26.09%11,651,597$9.55MInsider
Brenton Karl Ahrens3.88%1,733,580$1.42MInsider
Canaan X LP3.88%1,733,170$1.42MInsider
James Healy3.88%1,732,668$1.42MInsider
Patrick J. Heron3.46%1,547,322$1.27MInsider
Vijay K. Lathi3.26%1,456,303$1.19MInsider
Sofinnova Venture Partners IX LP2.75%1,226,514$1.01MInsider
Shahzad Malik1.94%868,161$711.89kInsider
Renaissance Technologies LLC1.06%471,900$386.96kInstitution
Ronald Hunt0.80%359,366$294.68kInsider

1 of 3

ITRM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITRM2.95%51.07%Net BuyingNet Buying
CALC5.55%94.45%Net BuyingNet Buying
XLO10.90%67.08%Net BuyingNet Buying
MRSN10.68%89.32%Net Selling
OKUR12.12%87.88%Net BuyingNet Selling
View Top Biotech Stocks

Iterum Therapeutics Stock Ownership FAQ

Who owns Iterum Therapeutics?

Iterum Therapeutics (NASDAQ: ITRM) is owned by 2.95% institutional shareholders, 51.07% Iterum Therapeutics insiders, and 45.98% retail investors. Ra Capital Management LP is the largest individual Iterum Therapeutics shareholder, owning 11.65M shares representing 26.09% of the company. Ra Capital Management LP's Iterum Therapeutics shares are currently valued at $9.55M.

If you're new to stock investing, here's how to buy Iterum Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.